A systematic review of statin efficacy in asthma

Journal of Asthma

Volumn 49, Issue 9, 2012, Pages 885-894

  Silva, Diana ^a   Couto, Mariana ^a,b   Delgado, Luís ^a,b   Moreira, André ^a,b  

^a Centro Hospitalar Universitário de São João   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Anti inflammatory agents; Asthma; Immunomodulation; Inflammation; Statins; Systematic review; Treatment outcome

Indexed keywords

ATORVASTATIN; CORTICOSTEROID; FLUINDOSTATIN; FLUTICASONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ASTHMA; DISEASE CONTROL; DRUG DOSE INCREASE; DRUG EFFICACY; FORCED EXPIRATORY VOLUME; HUMAN; LOW DRUG DOSE; LUNG FUNCTION; PEAK EXPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

ANTI-ASTHMATIC AGENTS; ASTHMA; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX;

EID: 84867554111     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2012.721433     Document Type: Review

References (62)

1. Arnaud C, Braunersreuther V, Mach F. Toward immunomodulatory and anti-inflammatory properties of statins. Trends Cardiovasc Med 2005; 15(6):202-206
2. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006; 113(19):2363-2372
3. Chow SC. Immunomodulation by statins: Mechanisms and potential impact on autoimmune diseases. Arch Immunol Ther Exp (Warsz) 2009; 57(4):243-251
4. Smaldone C, Brugaletta S, Pazzano V, Liuzzo G. Immunomodulator activity of 3-hydroxy-3-methilglutaryl-CoA inhibitors. Cardiovasc Hematol Agents Med Chem 2009; 7(4):279-294
5. Bu DX, Griffin G, Lichtman AH. Mechanisms for the anti-inflammatory effects of statins. Curr Opin Lipidol 2011; 22(3):165-170
6. Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178(3):218-224
7. Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D'Agostino R Jr, Castro M, Curran-Everett D, Fitzpatrick AM, Gaston B, Jarjour NN, Sorkness R, Calhoun WJ, Chung KF, Comhair SA, Dweik RA, Israel E, Peters SP, Busse WW, Erzurum SC, Bleecker ER; National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010; 181(4):315-323
8. Wenzel SE. Asthma: Defining of the persistent adult phenotypes. Lancet 2006; 368(9537):804-813
9. Bhakta NR, Woodruff PG. Human asthma phenotypes: From the clinic, to cytokines, and back again. Immunol Rev 2011; 242(1):220-232
10. Kim HY, DeKruyff RH, Umetsu DT. The many paths to asthma: Phenotype shaped by innate and adaptive immunity. Nat Immunol 2010; 11(7):577-584
11. Anderson GP. Endotyping asthma: New insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008; 372(9643):1107-1119
12. Agache I, Akdis C, Jutel M, Virchow JC. Untangling asthma phenotypes and endotypes. Allergy 2012; 67(7):835-846
13. Jeffery PK, Haahtela T. Allergic rhinitis and asthma: Inflammation in a one-airway condition. BMC Pulm Med 2006; 6(Suppl 1):S5
14. Imamura M, Okunishi K, Ohtsu H, Nakagome K, Harada H, Tanaka R, Yamamoto K, Dohi M. Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung. Thorax 2009; 64(1):44-49
15. McKay A, Leung BP, McInnes IB, Thomson NC, Liew FY. A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J Immunol 2004; 172(5):2903-2908
16. Review Manager (RevMan) [Computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008. Available from: Http://ims.cochrane.org/revman/about-revman-5
17. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochranehandbook. org 18. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, Jaeschke R, Rind D,Meerpohl J, DahmP, Schünemann HJ. GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011; 64(4):383-394
18. Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, Alderson P, Glasziou P, Falck-Ytter Y, Schünemann HJ. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 2011; 64(4):395-400
19. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011; 64(4):401-406
20. Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, Montori V, Akl EA, Djulbegovic B, Falck-Ytter Y, Norris SL, Williams JW Jr, Atkins D, Meerpohl J, Schünemann HJ. GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias). J Clin Epidemiol 2011; 64(4):407-415
21. Guyatt GH, Oxman AD, Schünemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 2011; 64(4):380-382
22. Huang CC, Chan WL, Chen YC, Chen TJ, Chou KT, Lin SJ, Chen JW, Leu HB. Statin use in patients with asthma - a nationwide populationbased study. Eur J Clin Invest 2011; 41(5):507-512
23. Braganza G, Chaudhuri R, McSharry C, Weir CJ, Donnelly I, Jolly L, Lafferty J, Lloyd SM, Spears M, Mair F, Thomson NC. Effects of shortterm treatment with atorvastatin in smokers with asthma - a randomized controlled trial. BMC Pulm Med 2011; 11(1):16
24. Maneechotesuwan K, Ekjiratrakul W, Kasetsinsombat K, Wongkajornsilp A, Barnes PJ. Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase. J Allergy Clin Immunol 2010; 126(4):754-762.e1
25. Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Simvastatin in the treatment of asthma: lack of steroid-sparing effect. Thorax 2010; 65(10):891-896
26. Ostroukhova M, Kouides RW, Friedman E. The effect of statin therapy on allergic patients with asthma. Ann Allergy Asthma Immunol 2009; 103(6):463-468
27. Hothersall EJ, Chaudhuri R, McSharry C, Donnelly I, Lafferty J, McMahon AD, Weir CJ, Meiklejohn J, Sattar N, McInnes I, Wood S, Thomson NC. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Thorax 2008; 63 (12):1070-1075
28. Fahimi F. Do statins improve lung function in asthmatic patients? A randomized and double blind trial. Iranian J Pharmaceut Sci 2009; 5(1):13-20
29. Menzies D, Nair A, Meldrum KT, Fleming D, Barnes M, Lipworth BJ. Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma. J Allergy Clin Immunol 2007; 119(2):328-335
30. Zeki AA, Kenyon NJ, Yoneda K, Louie S. The adult asthmatic. Clin Rev Allergy Immunol 2012 Aug; 43(1-2):138-55
31. Zeki AA, Kenyon NJ, Goldkorn T. Statin drugs, metabolic pathways, and asthma: A therapeutic opportunity needing further research. Drug Metabol Lett 2011; 5(1):40-44
32. Schaafsma D, Dueck G, Ghavami S, Kroeker A, Mutawe MM, Hauff K, Xu FY, McNeill KD, Unruh H, Hatch GM, Halayko AJ. The mevalonate cascade as a target to suppress extracellular matrix synthesis by human airway smooth muscle.Am J Respir Cell Mol Biol 2011; 44(3):394-403
33. Pawlak J, Zietkowski Z, Bodzenta-Lukaszyk A. [Beta-blockers and statins in the context of asthma]. Postepy Hig Med Dosw (Online) 2009; 63:634-642
34. Royce SG, Tang ML. The effects of current therapies on airway remodeling in asthma and new possibilities for treatment and prevention. Curr Mol Pharmacol 2009; 2(2):169-181
35. Robinson AJ, Kashanin D, O'Dowd F, Fitzgerald K, Williams V, Walsh GM. Fluvastatin and lovastatin inhibit granulocyte macrophage-colony stimulating factor-stimulated human eosinophil adhesion to inter-cellular adhesion molecule-1 under flow conditions. Clin Exp Allergy 2009; 39 (12):1866-1874
36. Shyamsundar M, McKeown ST, O'Kane CM, Craig TR, Brown V, Thickett DR, Matthay MA, Taggart CC, Backman JT, Elborn JS, McAuley DF. Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med 2009; 179(12):1107-1114
37. Feldman C. The role of statins in respiratory diseases. Clin Pulm Med 2009; 16(2):95-100
38. Rubin BK. Statins for the treatment of asthma: A discovery well, dry hole or just snake oil. Thorax 2009; 64(1):4-5
39. Camoretti-Mercado B. Targeting the airway smooth muscle for asthma treatment. Transl Res 2009; 154(4):165-174
40. Al Obaidi AHA, Al Samarai AGM. Evaluation anti-inflammatory and anti-oxidant activity of simvastatin in asthma. J Bahrain Med Soc 2008; 20(2):55-59
41. Walsh GM. Defective apoptotic cell clearance in asthma and COPD - a new drug target for statins? Trends Pharmacol Sci 2008; 29(1):6-11
42. Paraskevas KI, Tzovaras AA, Briana DD, Mikhailidis DP. Emerging indications for statins: A pluripotent family of agents with several potential applications. Curr Pharm Des 2007; 13(35):3622-3636
43. Takizawa H. Novel strategies for the treatment of asthma. Recent Pat Inflamm Allergy Drug Discov 2007; 1(1):13-19
44. Ennis M. New targets for modifying mast cell activation in asthma. Curr Allergy Asthma Rep 2006; 6(3):247-251
45. Ennis M. New therapeutic interventions in airway inflammatory and allergic diseases. Anti-Inflamm AntiAllergy Agents Med Chem 2006; 5(4):353-356
46. Samson KT, Minoguchi K, Tanaka A, Oda N, Yokoe T, Yamamoto Y, Yamamoto M, Ohta S, Adachi M. Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma. Clin Exp Allergy 2006; 36(4): 475-482
47. Hillas G, Kostikas K,Mantzouranis K, Bessa V, Kontogianni K, Papadaki G, Papiris S, Alchanatis M, Loukides S, Bakakos P. Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers. Respirology 2011; 16(5):811-818
48. Hothersall E, McSharry C, Thomson NC. Potential therapeutic role for statins in respiratory disease. Thorax 2006; 61(8):729-734
49. Hakamada-Taguchi R, Uehara Y, Kuribayashi K, Numabe A, Saito K, Negoro H, Fujita T, Toyo-oka T, Kato T. Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development. Circ Res 2003; 93(10):948-956
50. Coward W, Chow SC. Effect of atorvastatin on TH1 and TH2 cytokine secreting cells during T cell activation and differentiation. Atherosclerosis 2006; 186(2):302-309
51. Zhang X, Markovic-Plese S. Statins' immunomodulatory potential against Th17 cell-mediated autoimmune response. Immunol Res 2008; 41(3):165-174
52. Kim DY, Ryu SY, Lim JE, Lee YS, Ro JY. Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model. Eur J Pharmacol 2007; 557(1):76-86
53. Zeki AA, Bratt JM, Rabowsky M, Last JA, Kenyon NJ. Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: A novel treatment for airway remodeling? Transl Res 2010; 156(6):335-349
54. Zeki AA, Franzi L, Last J, Kenyon NJ. Simvastatin inhibits airway hyperreactivity: Implications for the mevalonate pathway and beyond. Am J Respir Crit Care Med 2009; 180(8):731-740
55. El-Haibi C, Rahal E, Khauli RB, Abdelnoor AM. Effect of atorvastatin on antibody, interleukin-4 and gamma-interferon production in mice immunized with egg albumin. Immunopharmacol Immunotoxicol 2006; 28(3):459-470
56. Yeh YF, Huang SL. Enhancing effect of dietary cholesterol and inhibitory effect of pravastatin on allergic pulmonary inflammation. J Biomed Sci 2004; 11(5):599-606
57. Chiba Y, Sato S, Misawa M. Upregulation of geranylgeranyltransferase I in bronchial smooth muscle of mouse experimental asthma: Its inhibition by lovastatin. J Smooth Muscle Res 2010; 46(1):57-64
58. Chiba Y, Sato S, Misawa M. Inhibition of antigen-induced bronchial smooth muscle hyperresponsiveness by lovastatin in mice. J Smooth Muscle Res 2008; 44(3-4):123-128
59. Ahmad T, Mabalirajan U, Sharma A, Aich J, Makhija L, Ghosh B, Agrawal A. Simvastatin improves epithelial dysfunction and airway hyperresponsiveness: From asymmetric dimethyl-arginine to asthma. Am J Respir Cell Mol Biol 2011; 44(4):531-539
60. Agrawal A, Mabalirajan U, Ahmad T, Ghosh B. Emerging interface between metabolic syndrome and asthma. Am J Respir Cell Mol Biol 2011; 44(3):270-275
61. Ramalho R, Almeida J, Beltrão M, Pirraco A, Costa R, Sokhatska O, Guardão L, Palmares C, Guimarães JT, Delgado L, Moreira A, Soares R. Neurogenic inflammation in allergen-challenged obese mice: A missing link in the obesityasthma association? Exp Lung Res 2012; 38(6): 316-24
62. Matera MG, Calzetta L, Rinaldi B, Cazzola M. Treatment of COPD: Moving beyond the lungs. Curr Opin Pharmacol 2012; 12(3):315-22. Epub 2012 Apr 30